Characterization of a New Breast Cancer Antigen
Author Information
Author(s): S.A. Stacker, J.J. Tjandra, Pei-Xiang Xing, I.D. Walker, C.H. Thompson, I.F.C. McKenzie
Primary Institution: University of Melbourne
Hypothesis
The study aims to isolate and characterize a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
Conclusion
The study identifies a unique high molecular weight glycoprotein, MSA, that is present in breast cancer patients but not in normal human milk.
Supporting Evidence
- MSA was isolated from the sera, ascites, and breast carcinoma tissue of patients with breast cancer.
- MSA was found to be a high molecular weight glycoprotein with a molecular weight greater than 300,000.
- MSA+ molecules were found to express repeated 3E1.2 defined epitopes.
- MSA was detected in serum with elevated levels in a high proportion of patients with localized or disseminated breast cancer.
Takeaway
Researchers found a special protein in breast cancer patients' blood that helps identify the disease, but this protein is not found in normal milk.
Methodology
The study used immunoaffinity chromatography and solid phase immuno-precipitation techniques to isolate and characterize the MSA protein.
Limitations
The study does not specify the limitations encountered during the research.
Participant Demographics
The study involved patients with metastatic breast cancer.
Want to read the original?
Access the complete publication on the publisher's website